Hypertensive disorders of pregnancy cause 14% of maternal deaths each year worldwide. Aren't 57,000 mommy deaths ca… https://t.co/4uH7GVT71p
The Letter of Intent period is CLOSED for the 2020 Peter Joseph Pappas Research Grants funding program. Decisions will be rendered in December 2020 and the next funding round will be announced next year.
The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year. Read the full announcement.
Questions? Contact [email protected]
According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Foundation’s Vision Grant Program fund medical research pertaining to the pathophysiology, diagnosis, and treatment of hypertensive disorders of pregnancy.
The Preeclampsia Foundation, through the generous support of our donors, corporate partnerships, and community events such as The Promise Walk for Preeclampsia, has supported more than $550,000 in research since its founding in 2000. Successful projects have, in turn, garnered additional research support from major funding organizations, earned scientific merit at important meetings, and inspired young investigators to commit their life’s work to this complex field of study.
On February 13, 2019, the Preeclampsia Foundation announced at the Society for Maternal-Fetal Medicine’s (SMFM) 39th Annual Meeting that applications are now being accepted for its 2019 Vision Grant program.
The Preeclampsia Foundation will award up to two medical research Vision Grants to study preeclampsia and related hypertensive disorders of pregnancy, up to $20,000 USD each. The Foundation’s Canadian affiliate, Preeclampsia Foundation Canada, will also award one Vision Grant up to $20,000 CAD, to a Canadian researcher.
Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows, or Early Stage Investigators only are eligible to apply. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any wellconsidered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English.
Please note: The application period is closed and we are not currently accepting applications.
Read the full announcement
Application checklist (fillable form)
Questions? Contact [email protected]
EMPOWER (EMpowering Progress in Obstetric and Women's hEalth Research) was established to create partnerships between mentors and single sites or groups within low- and middle-income countries to improve clinical and health services research into the hypertensive disorders of pregnancy.
Funding is available up to $60,000 USD for a two-year research project. The immediate objective will be the completion of a project designed by a local investigator and, when appropriate, the dissemination of the results of the study to change practice and improve care.
EMPOWER is a collaboration of the International Society for the Study of Hypertension in Pregnancy, the Preeclampsia Foundation, PRE-EMPT/Global Pregnancy Collaboration, and supporting organization New Zealand Action on Pre-eclampsia.
EMPOWER Program Announces 2016 Recipient
The Preeclampsia Foundation, along with its partners International Society for the Study of Hypertension in Pregnancy (ISSHP) and the PRE-EMPT/Global Pregnancy Collaboration (CoLab), announced the recipient of their EMPOWER Award for preeclampsia-related research at the opening ceremonies of the World Congress of ISSHP. Dr. Sarah Manyame, a physician-researcher with the Department of Obstetrics and Gynaecology at the University of Zimbabwe Parirenvatwa Group of Hospitals, was awarded $60,000 USD for her two-year project “Urine Biomarkers for Preeclampsia in High Risk Women.” Dr. James Roberts with the Magee-Womens Research Institute in Pittsburgh, Pennsylvania, will serve as Dr. Manyame’s mentor.
Please note: The application period is closed and we are not currently accepting applications.
Read the entire announcement
Questions? Contact [email protected]
The Preeclampsia Registry is a "Living Database" bringing together those affected, their family members, and researchers to advance knowledge and discover preventions and treatments for preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy.
